from The American Heritage® Dictionary of the English Language, 4th Edition
- n. A malignant tumor formed by the cells of the bone marrow.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. A malignant tumour arising from cells of the bone marrow, specifically plasma cells.
from The Century Dictionary and Cyclopedia
- n. A giant-celled sarcoma.
- n. A tumor of the bone-marrow, often multiple.
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- n. a tumor of the bone marrow (usually malignant) composed of cells normally found in bone marrow
Sorry, no etymologies found.
I suffer from something called myeloma, which is a rare cancer of the bone.
In December of 1998, I, too, was diagnosed with a blood cancer, multiple myeloma, which is also not curable.
I am just wondering -- my mom has multiple myeloma, which is a bone-marrow cancer.
He died of myeloma, which is cancer of the bone, and he did not want my mother to bear the pain of having to take care of him so he came to Washington and he was here for two months and he died by my side -- it was just the two of us -- about 5 a.m. one Monday morning.
When she became Millennium's CEO, Velcade was approved in the U.S. only as a second-line treatment for patients who have already taken other drugs of multiple myeloma, which is often fatal.
Multiple myeloma (also known as myeloma or plasma cell myeloma) is a cancer of the blood in which malignant plasma cells are overproduced in the bone marrow.
Multiple myeloma, also known as myeloma or plasma cell myeloma, is cancer of the plasma cells
According to the Multiple Myeloma Research Foundation, multiple myeloma (also known as myeloma or plasma cell myeloma) is a progressive hematologic (blood) disease.
He had multiple myeloma, which is cancer of the plasma cells that produce antibodies to help fight disease.
The medicine is designed to keep multiple myeloma, which is incurable, under control and provide patients with precious extra months of life.
Wordnik is becoming a not-for-profit! Read our announcement here.